L
Lei Liu
Researcher at Southern University of Science and Technology
Publications - 141
Citations - 48147
Lei Liu is an academic researcher from Southern University of Science and Technology. The author has contributed to research in topics: Medicine & Antibody. The author has an hindex of 44, co-authored 123 publications receiving 34909 citations. Previous affiliations of Lei Liu include Guangzhou Medical University & Nanjing University.
Papers
More filters
Journal ArticleDOI
Clinical Characteristics of Coronavirus Disease 2019 in China.
Wei-jie Guan,Zhengyi Ni,Yu Hu,Wenhua Liang,Chun-Quan Ou,Jianxing He,Lei Liu,Hong Shan,Chunliang Lei,David S.C. Hui,Bin Du,Lanjuan Li,Guang Zeng,Kowk-Yung Yuen,Ruchong Chen,Chun-Li Tang,Tao Wang,Ping-Yan Chen,Jie Xiang,Shiyue Li,Jinlin Wang,Zi-jing Liang,Yi-xiang Peng,Li Wei,Yong Liu,Ya-hua Hu,Peng Peng,Jian-ming Wang,Ji-yang Liu,Zhong Chen,Gang Li,Zhi-jian Zheng,Shao-qin Qiu,Jie Luo,Chang-jiang Ye,Shao-yong Zhu,Nanshan Zhong +36 more
TL;DR: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness, and patients often presented without fever, and many did not have abnormal radiologic findings.
Journal ArticleDOI
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.
Wei Jie Guan,Wenhua Liang,Yi Zhao,Heng Rui Liang,Zi Sheng Chen,Yimin Li,Xiaoqing Liu,Ru Chong Chen,Chun Li Tang,Tao Wang,Chun-Quan Ou,Li Li,Ping Yan Chen,Ling Sang,Wei Wang,Jianfu Li,Caichen Li,Li Min Ou,Bo Cheng,Shan Xiong,Zheng Yi Ni,Jie Xiang,Yu Hu,Lei Liu,Hong Shan,Chun Liang Lei,Yi Xiang Peng,Li Wei,Yong Liu,Ya Hua Hu,Peng Peng,Jian-ming Wang,Ji Yang Liu,Zhong Chen,Gang Li,Zhi Jian Zheng,Shao Qin Qiu,Jie Luo,Chang Jiang Ye,Shao Yong Zhu,Lin Ling Cheng,Feng Ye,Shi Yue Li,Jin Ping Zheng,Nuo Fu Zhang,Nanshan Zhong,Jianxing He +46 more
TL;DR: It is found that among laboratory confirmed cases of COVID-19, patients with any comorbidity yielded poorer clinical outcomes than those without and a greater number ofComorbidities also correlated with poorer clinical outcome.
Journal ArticleDOI
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.
Juanjuan Zhao,Quan Yuan,Haiyan Wang,Wei Liu,Xuejiao Liao,Yingying Su,Xin Wang,Jing Yuan,Tingdong Li,Jinxiu Li,Shen Qian,Congming Hong,Fuxiang Wang,Yingxia Liu,Zhaoqin Wang,Qing He,Zhiyong Li,Bin He,Tianying Zhang,Yang Fu,Shengxiang Ge,Lei Liu,Jun Zhang,Ningshao Xia,Zheng Zhang +24 more
TL;DR: The findings provide strong empirical support for the routine application of serological testing in the diagnosis and management of COVID-19 patients and offer vital clinical information during the course of SARS-CoV-2 infection.
Journal ArticleDOI
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Chenguang Shen,Zhaoqin Wang,Fang Zhao,Yang Yang,Jinxiu Li,Jing Yuan,Fuxiang Wang,Delin Li,Delin Li,Minghui Yang,Li Xing,Jinli Wei,Haixia Xiao,Haixia Xiao,Yan Yang,Jiuxin Qu,Ling Qing,Li Chen,Zhixiang Xu,Ling Peng,Yanjie Li,Haixia Zheng,Feng Chen,Kun Huang,Yujing Jiang,Dongjing Liu,Zheng Zhang,Yingxia Liu,Lei Liu +28 more
TL;DR: In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, administration of convalescent plasma containing neutralizing antibody was followed by improvement in their clinical status, and these observations require evaluation in clinical trials.
Journal ArticleDOI
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.
Yingxia Liu,Yang Yang,Cong Zhang,Cong Zhang,Fengming Huang,Fuxiang Wang,Jing Yuan,Zhaoqin Wang,Jinxiu Li,Jianming Li,Cheng Feng,Zheng Zhang,Lifei Wang,Ling Peng,Li Chen,Yuhao Qin,Dandan Zhao,Shuguang Tan,Lu Yin,Jun Xu,Cong-Zhao Zhou,Chengyu Jiang,Lei Liu +22 more
TL;DR: The epidemiological, clinical, laboratory, and radiological characteristics, as well as potential biomarkers for predicting disease severity in 2019-nCoV-infected patients in Shenzhen, China, suggest a number of potential diagnosis biomarkers and angiotensin receptor blocker drugs for potential repurposing treatment of 2019- nCoV infection.